Dr Ian Furtado, MD | |
204 E 15th St, Alma, GA 31510-2908 | |
(912) 632-2952 | |
(912) 632-8682 |
Full Name | Dr Ian Furtado |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 8 Years |
Location | 204 E 15th St, Alma, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912358755 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 83601 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Amedisys Home Health | Waycross, GA | Home health agency |
Bacon County Hospital | Alma, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bacon County Health Services, Inc. | 1850294034 | 7 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announce the signing of an agreement whereby Quick-Med Technologies has granted Derma Sciences an exclusive global license to intellectual property related to the novel NIMBUS antimicrobial technology, which is available in BIOGUARD dressings.
The bScreen combines the performance of µArray formats with the information available from label-free technologies. With a footprint of only 66 x 61 cm2 it substitutes a fluorescence µArray reader and a conventional label-free system (e.g. SPR) in a single instrument.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
Investigators at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart - a breakthrough that may open up new cardiac pacing options for children and adults.
› Verified 1 days ago
Entity Name | Bacon County Health Services, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629185285 PECOS PAC ID: 1850294034 Enrollment ID: O20040127001164 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announce the signing of an agreement whereby Quick-Med Technologies has granted Derma Sciences an exclusive global license to intellectual property related to the novel NIMBUS antimicrobial technology, which is available in BIOGUARD dressings.
The bScreen combines the performance of µArray formats with the information available from label-free technologies. With a footprint of only 66 x 61 cm2 it substitutes a fluorescence µArray reader and a conventional label-free system (e.g. SPR) in a single instrument.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
Investigators at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart - a breakthrough that may open up new cardiac pacing options for children and adults.
› Verified 1 days ago
Entity Name | South Georgia Physicians Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336560952 PECOS PAC ID: 8224208251 Enrollment ID: O20110831000412 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announce the signing of an agreement whereby Quick-Med Technologies has granted Derma Sciences an exclusive global license to intellectual property related to the novel NIMBUS antimicrobial technology, which is available in BIOGUARD dressings.
The bScreen combines the performance of µArray formats with the information available from label-free technologies. With a footprint of only 66 x 61 cm2 it substitutes a fluorescence µArray reader and a conventional label-free system (e.g. SPR) in a single instrument.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
Investigators at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart - a breakthrough that may open up new cardiac pacing options for children and adults.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ian Furtado, MD 204 E 15th St, Alma, GA 31510-2908 Ph: (912) 632-2952 | Dr Ian Furtado, MD 204 E 15th St, Alma, GA 31510-2908 Ph: (912) 632-2952 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announce the signing of an agreement whereby Quick-Med Technologies has granted Derma Sciences an exclusive global license to intellectual property related to the novel NIMBUS antimicrobial technology, which is available in BIOGUARD dressings.
The bScreen combines the performance of µArray formats with the information available from label-free technologies. With a footprint of only 66 x 61 cm2 it substitutes a fluorescence µArray reader and a conventional label-free system (e.g. SPR) in a single instrument.
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
Investigators at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart - a breakthrough that may open up new cardiac pacing options for children and adults.
› Verified 1 days ago
Michael S. Deen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 203 S Wayne St, Alma, GA 31510 Phone: 912-632-8288 Fax: 912-632-8458 | |
Mr. Aubrey Glynn Moore, PHYSICIANS ASSISTANT Family Medicine Medicare: Medicare Enrolled Practice Location: 143 Hwy 32 Byp, Michael S. Deen M.d., Alma, GA 31510 Phone: 912-632-8288 Fax: 912-632-3758 |